Article Versions Notes

Kulkoyluoglu-Cotul E, Smith BP, Wrobel K, Chen Zhao Y, Chen KLA, Hieronymi K, Imir OB, Duong K, O’Callaghan C, Mehta A, et al. Combined Targeting of Estrogen Receptor Alpha and XPO1 Prevent Akt Activation, Remodel Metabolic Pathways and Induce Autophagy to Overcome Tamoxifen Resistance. Cancers. 2019; 11(4):479. https://doi.org/10.3390/cancers11040479

Kulkoyluoglu-Cotul, Eylem, Brandi Patrice Smith, Kinga Wrobel, Yiru Chen Zhao, Karen Lee Ann Chen, Kadriye Hieronymi, Ozan Berk Imir, Kevin Duong, Caitlin O’Callaghan, Aditi Mehta, and et al. 2019. "Combined Targeting of Estrogen Receptor Alpha and XPO1 Prevent Akt Activation, Remodel Metabolic Pathways and Induce Autophagy to Overcome Tamoxifen Resistance" Cancers 11, no. 4: 479. https://doi.org/10.3390/cancers11040479

Kulkoyluoglu-Cotul, E., Smith, B. P., Wrobel, K., Chen Zhao, Y., Chen, K. L. A., Hieronymi, K., Imir, O. B., Duong, K., O’Callaghan, C., Mehta, A., Sahoo, S., Haley, B., Chang, H., Landesman, Y., & Madak-Erdogan, Z. (2019). Combined Targeting of Estrogen Receptor Alpha and XPO1 Prevent Akt Activation, Remodel Metabolic Pathways and Induce Autophagy to Overcome Tamoxifen Resistance. Cancers, 11(4), 479. https://doi.org/10.3390/cancers11040479